Abstract
Background
Neuromuscular disorders are not among the common causes of cardiomyopathy in the general population; however, cardiomyopathy is known to occur in several neuromuscular disorders including Friedreich’s Ataxia (FA). In patients with neuromuscular disorders, concomitant cardiac involvement contributes significantly to morbidity and mortality and often leads to premature death.
Methods
An extensive literature search of Medline and Pubmed was conducted to include all published reports on cardiac involvement in FA. Secondary articles were identified from key paper reference listings.
Conclusion
Hypertrophic cardiomyopathy is a cardinal feature of FA; therefore all FA patients should be screened for cardiomyopathy. A cardiac examination, ECG and ECHO are advised at diagnosis, and also on the development of any cardiac symptoms. Treatment is determined by the presence of symptoms, the presence of left ventricular outflow gradient and the sudden death risk. Institution of aggressive medical therapy early in the course of the disease may help improve quality of life and provide survival benefit.
Similar content being viewed by others
References
Chamberlain S, Shaw J, Rowland A et al (1988) Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 334(6179):248–250
Delatycki MB, Williamson R, SM Forrest (2000) Friedreich ataxia: an overview. J Med Genet 37(1):1–8
Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA (1986) Cardiac involvement in Friedreich’s ataxia: a clinical study of 75 patients. J Am Coll Cardiol 7(6):1370–1378
Lewis WR, Yadlapalli S (1998) Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 9(1):145–66, vii
Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589–620
De Michele GPF (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich’s disease: a retrospective study on 119 patients. Neurology 47:1260–1264
Filla A, DeMichele G, Caruso G, Marconi R, Campanella G (1990) Genetic data and natural history of Friedreich’s disease: a study of 80 Italian patients. J Neurol 237(6):345–351
Casazza F, Ferrari F, Piccone U, Maggiolini S, Capozi A, Morpurgo M (1990) Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study. Cardiologia 35(5):423–431
Casazza F, Morpurgo M (1996) The varying evolution of Friedreich’s ataxia cardiomyopathy. Am J Cardiol 77(10):895–898
Durr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335(16):1169–1175
Bit-Avragim N, Perrot A, Schols L et al (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich’s ataxia. J Mol Med 78(11):626–632
Hewer R (1969) The heart in Friedreich’s ataxia. Br Heart J 31(1):5–14
Asaad NE-MA, Al Suwaidi J (2010) Recurrent ventricular tachycardia in patient with Friedreich’s ataxia in the absence of clinical myocardial disease. Pacing Clin Electrophysiol 33(1):109–112
Groh W (2004). In: Zipes DP, Jalife J (eds) Arrhythmias in patients with neurologic disorders, in cardiac electrophysiology: from cell to bedside. WB Saunders, Philadelphia, pp 640–650
SP Giugliano GR (2007) Friedreich’s ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 34(2):214–217
Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147
Alboliras ET, Shub C, Gomez MR et al (1986) Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 58(6):518–524
Hewer RL (1968) Study of fatal cases of Friedreich’s ataxia. Br Med J 3(5619):649–652
Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42(9):1687–1713
Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016
CM Sedlak TL, Straatman L (2004) Cardiac transplantation: a temporary solution for Friedreich’s ataxia-induced dilated cardiomyopathy. J Heart Lung Transplant 23:1304–1306
Segovia J A-PL, Burgos R, L. Silva, et al (2001) Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases. J Heart Lung Transpl 20:169
E-BA Yoda M, Arusoglu L, Tendrich G, Minami K, Korfer R (2006) Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich’s ataxia. J Heart Lung Transplant 25:251–252
Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the Surgeons. J Am Coll Cardiol 51(21):e1–e62
Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48(5):e247–e346
Walker S, Levy T, Rex S, Paul VE (1999) Biventricular implantable cardioverter defibrillator use in a patient with heart failure and ventricular tachycardia secondary to Emery-Dreifuss syndrome. Europace 1(3):206–209
Luethje LG, Boennemann C, Goldfarb L, Goebel HH, Halle M (2004) Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. Pacing Clin Electrophysiol 27(4):559–560
Acknowledgments
There was no financial incentive or input into this article.
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bourke, T., Keane, D. Friedreich’s Ataxia: a review from a cardiology perspective. Ir J Med Sci 180, 799–805 (2011). https://doi.org/10.1007/s11845-011-0744-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-011-0744-y